1,996 results on '"McCluggage, W Glenn"'
Search Results
102. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
103. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors
104. Late Development of Metastatic Ovarian Mucinous Adenocarcinoma From Primary Gallblader Adenocarcinoma and High-grade Dysplasia
105. Microsatellite Instability in Non-Endometrioid Ovarian Epithelial Tumors: A study of 400 cases Comparing Immunohistochemistry, PCR, and NGS Based Testing with Mutation Status of MMR Genes.
106. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions
107. Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups
108. Benign Endocervical Glandular Lesions
109. Other Neoplasms of the Cervix
110. Malignant Glandular Lesions of the Cervix
111. Premalignant Glandular Lesions of the Cervix
112. Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases
113. Ovarian Immature Teratoma With Nodal Gliomatosis: A Case Report and Literature Review.
114. Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer
115. Primary Ovarian High-grade Neuroendocrine Carcinoma With Merkel Cell–like Immunophenotype Arising in a Teratoma
116. Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations
117. Low-grade Serous Carcinoma Arising in Inguinal Nodal Endosalpingiosis: Report of 2 Cases and Literature Review
118. Uterine Endometrial Stromal Tumors With Limited Infiltration: First Report of a Case Series Indicating Potential for Malignant Behavior
119. A Clinicopathologic Study and Descriptive Analysis of “Atypical Endosalpingiosis”
120. Endometrial Gastric (Gastrointestinal)-type Mucinous Lesions: Report of a Series Illustrating the Spectrum of Benign and Malignant Lesions
121. Primary Angiosarcoma of the Cervix: Case Report of a Rare Lesion
122. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma
123. Multiple Epidermolytic Acanthomas: Rare Vulval Lesions Which May be Mistaken for Viral Warts
124. Ovarian Combined Brenner Tumor, Mucinous Cystadenoma and Struma Ovarii: First Report of a Rare Combination
125. Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO)
126. YWHAE-NUTM2A/B Translocated High-grade Endometrial Stromal Sarcoma Commonly Expresses CD56 and CD99
127. Primary Angiosarcoma of the Cervix: Case Report of a Rare Lesion
128. The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines
129. Supplementary Data from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
130. Supplementary Data from Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
131. Supplementary Data from Predicting Clinical Outcome in Patients Diagnosed with Synchronous Ovarian and Endometrial Cancer
132. Supplementary Data from PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
133. Mesonephric‐like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas
134. Data from Clinicopathological Features of Homologous Recombination–Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival
135. Supplementary Figure 2 from Clinicopathological Features of Homologous Recombination–Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival
136. Supplementary Figure 1 from Clinicopathological Features of Homologous Recombination–Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival
137. Supplementary Figure Legends 1-2 from Clinicopathological Features of Homologous Recombination–Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival
138. Genomic characterization of DICER1-associated neoplasms uncovers molecular classes
139. High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker
140. Tumour grading: communication is the key
141. Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK
142. Cervical Gastric-type Adenosquamous Carcinoma: Case Report of a Rare Neoplasm Associated With a BRCA1 Pathogenic Variant
143. Rare non-epithelial ovarian neoplasms: Pathology, genetics and treatment
144. Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): A Review with Recent Developments on Pathogenesis
145. A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus
146. Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
147. The evolving spectrum of endocervical adenocarcinoma in situ (AIS)
148. Overview of Epithelial Ovarian Carcinoma (EOC): Pathogenesis and General Considerations
149. Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract
150. Reclassifying endometrial carcinomas with a combined morphological and molecular approach
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.